Estimating burden and disease costs of exposure to endocrine-disrupting chemicals in the European Union

Journal of Clinical Endocrinology and Metabolism

Volumn 100, Issue 4, 2015, Pages 1245-1255

  Trasande, Leonardo ^a,b,c,d   Zoeller, R Thomas ^e   Hass, Ulla ^f   Kortenkamp, Andreas ^g   Grandjean, Philippe ^h,i   Myers, John Peterson ^j   Digangi, Joseph ^k   Bellanger, Martine ^l   Hauser, Russ ^g   Legler, Juliette ^m   Skakkebaek, Niels E ⁿ   Heindel, Jerrold J ^o  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NEW YORK UNIVERSITY   (United States)

^c NEW YORK UNIVERSITY   (United States)

^d NEW YORK UNIVERSITY   (United States)

^e UNIVERSITY OF MASSACHUSETTS   (United States)

^f TECHNICAL UNIVERSITY OF DENMARK   (Denmark)

^g BRUNEL UNIVERSITY   (United Kingdom)

^h HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

ⁱ UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^j Environmental Health Sciences   (United States)

^k IPEN   (Sweden)

^l EHESP School of Public Health   (France)

^m VU UNIVERSITY AMSTERDAM   (Netherlands)

ⁿ UNIVERSITY OF COPENHAGEN   (Denmark)

^o NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

1,1 DICHLORO 2,2 BIS(4 CHLOROPHENYL)ETHYLENE; 4,4' ISOPROPYLIDENEDIPHENOL; ENDOCRINE DISRUPTOR; ORGANOPHOSPHATE PESTICIDE; PHTHALIC ACID; PHTHALIC ACID BENZYL BUTYL ESTER; PHTHALIC ACID BIS(2 ETHYLHEXYL) ESTER; POLYBROMINATED DIPHENYL ETHER; TESTOSTERONE; POLLUTANT;

ARTICLE; ATTENTION DEFICIT DISORDER; AUTISM; BODY BURDEN; CAUSAL ATTRIBUTION; CHILDHOOD OBESITY; CLIMATE CHANGE; CONSENSUS DEVELOPMENT; CRYPTORCHISM; DELPHI STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; ECONOMIC EVALUATION; ENVIRONMENTAL EXPOSURE; EPIDEMIOLOGICAL DATA; EUROPEAN UNION; HEALTH CARE COST; HEALTH CARE ORGANIZATION; HUMAN; INTELLECTUAL IMPAIRMENT; INTELLIGENCE QUOTIENT; MALE INFERTILITY; MONTE CARLO METHOD; MORTALITY; NONHUMAN; OBESITY; PRIORITY JOURNAL; PROBABILITY; QUANTITATIVE ANALYSIS; ADULT; AGED; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; AUTISTIC DISORDER; CHEMICALLY INDUCED; CHILD; COST OF ILLNESS; ECONOMICS; ENDOCRINE SYSTEM DISEASES; FEMALE; MALE; MIDDLE AGED; POLLUTANT; STATISTICS AND NUMERICAL DATA; TOXICITY;

ANIMALIA;

ADULT; AGED; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; AUTISTIC DISORDER; CHILD; COST OF ILLNESS; ENDOCRINE DISRUPTORS; ENDOCRINE SYSTEM DISEASES; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL POLLUTANTS; EUROPEAN UNION; FEMALE; HUMANS; MALE; MIDDLE AGED;

EID: 84927647942     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2014-4324     Document Type: Article

References (75)

1. Nohynek GJ, Borgert CJ, Dietrich D, Rozman KK. Endocrine disruption: fact or urban legend? Toxicol Lett. 2013;223:295-305.
2. Damstra T, Barlow S, Bergman A, Kavlock RJ, Van Der Kraak G, eds. Global Assessment of the State-of-the-Science of Endocrine Disruptors. International Programme on Chemical Safety. Geneva, Switzerland: World Health Organization; 2002.
3. Zoeller RT, Brown TR, Doan LL, et al. Endocrine-disrupting chemicals and public health protection: a statement of principles from The Endocrine Society. Endocrinology. 2012;153:4097-4110.
4. Steinmaus C, Miller MD, Cushing L, Blount BC, Smith AH. Combined effects of perchlorate, thiocyanate, and iodine on thyroid function in the National Health and Nutrition Examination Survey 2007-08. Environ Res. 2013;123:17-24.
5. Nadal A, Alonso-Magdalena P, Soriano S, Quesada I, Ropero AB. The pancreatic β-cell as a target of estrogens and xenoestrogens: implications for blood glucose homeostasis and diabetes. Mol Cell Endocrinol. 2009;304:63-68.
6. Bergman A, Heindel JJ, Jobling S, Kidd KA, Zoeller RT. State of the Science of Endocrine Disrupting Chemicals 2012. Geneva, Switzerland: United Nations Environment Programme and World Health Organization; 2013.
7. Bern H. The fragile fetus. In: Colborn T, Clement C, eds. Chemically-Induced Alteration in Sexual and Functional Development: The Wildlife/Human Connection. Princeton, NJ: Princeton Scientific Publishing; 1992:9-15.
8. Shea KM, American Academy of Pediatrics Committee on Environmental Health. Pediatric exposure and potential toxicity of phthalate plasticizers. Pediatrics. 2003;111:1467-1474.
9. Howdeshell KL, Hotchkiss AK, Thayer KA, Vandenbergh JG, vom Saal FS. Exposure to bisphenol A advances puberty. Nature. 1999;401:763-764.
10. Longnecker MP, Klebanoff MA, Brock JW, et al. Maternal serum level of 1, 1-dichloro-2, 2-bis (p-chlorophenyl) ethylene and risk of cryptorchidism, hypospadias, and polythelia among male offspring. Am J Epidemiol. 2002;155:313-322.
11. Gore AC. Organochlorine pesticides directly regulate gonadotropin-releasing hormone gene expression and biosynthesis in the GT1-7hypothalamic cell line. Mol Cell Endocrinol. 2002;192:157-170.
12. Chevrier J, Harley KG, Bradman A, Gharbi M, Sjödin A, Eskenazi B. Polybrominated diphenyl ether (PBDE) flame retardants and thyroid hormoneduringpregnancy. Environ Health Perspect. 2010;118:1444-1449.
13. Herbstman JB, Sjödin A, Apelberg BJ, et al. Birth delivery mode modifies the associations between prenatal polychlorinated biphenyl (PCB) and polybrominated diphenyl ether (PBDE) and neonatal thyroid hormone levels. Environ Health Perspect. 2008;116:1376-1382.
14. Takeuchi S, Iida M, Kobayashi S, Jin K, Matsuda T, Kojima H. Differential effects of phthalate esters on transcriptional activities via human estrogen receptors and β, and and rogen receptor. Toxicology. 2005;210:223-233.
15. Zhou T, Ross DG, DeVito MJ, Crofton KM. Effects of short-term in vivo exposure to polybrominated diphenyl ethers on thyroid hormones and hepatic enzyme activities in weanling rats. Toxicol Sci. 2001:61:76-82.
16. Zoeller RT, Bansal R, Parris C. Bisphenol-A, an environmental contaminant that acts as a thyroid hormone receptor antagonist in vitro, increases serum thyroxine, and alters RC3/neurogranin expression in the developing rat brain. Endocrinology. 2005;146:607-612.
17. Colborn T. Neurodevelopment and endocrine disruption. Environ Health Perspect. 2004;112:944-949.
18. Desvergne B, Feige JN, Casals-Casas C. PPAR-mediated activity of phthalates: a link to the obesity epidemic? Mol Cell Endocrinol. 2009;304:43-48.
19. Hauser R. The environment and male fertility: recent research on emerging chemicals and semen quality. Semin Reprod Med. 2006;24:156-167.
20. Cohn BA, Wolff MS, Cirillo PM, Sholtz RI. DDT and breast cancer in young women: new data on the significance of age at exposure. Environ Health Perspect. 2007;115:1406-1414.
21. Chapin RE, Adams J, Boekelheide K, et al. NTP-CERHR expert panel report on the reproductive and developmental toxicity of bisphenol A. Birth Defects Res B Dev Reprod Toxicol. 2008;83:157-395.
22. Carwile JL, Michels KB. Urinary bisphenolAand obesity: NHANES 2003-2006. Environ Res. 2011;111:825-830.
23. Trasande L, Attina TM, Blustein J. Association between urinary bisphenol A concentration and obesity prevalence in children and adolescents. JAMA. 2012;308:1113-1121.
24. Bergman Å, Heindel J, Jobling S, Kidd KA, Zoeller RT, eds. State of the science of endocrine disrupting chemicals, 2012. United Nations Environment Programme and the World Health Organization. http://www.who.int/ceh/publications/endocrine/en/. Published 2013. Accessed October 6, 2014.
25. European Commission 2010 REACH. http://echa.europa.eu/regulations/reach. Accessed December 8, 2010.
26. United Nations Environment Programme. Strategic Approach to International Chemicals Management. http://www.saicm.org/index.php?ql=h&content=home. Published 2010. Accessed December 8, 2010.
27. European Commission. Endocrine disruptors. http://ec.europa.eu/environment/chemicals/endocrine/index-en. htm. Published 2013. Accessed May 12, 2014.
28. Institute of Medicine. Costs of environment-related health effects. Committee for a Planning Study on Ongoing Study of Costs of Environmental-Related Health Effects. Washington DC: National Academy Press; 1981.
29. Smith KR, Corvalán CF, Kjellström T. How much global ill health is attributable to environmental factors? Epidemiology. 1999;10:573-584.
30. Hanley JA. A heuristic approach to the formulas for population attributable fraction. J Epidemiol Community Health. 2001;55:508-514.
31. Hill A. The environment and disease: association or causation? Proc R Soc Med. 1965;58:295-300.
32. Intergovernmental Panel on Climate Change. Guidance Notes for Lead Authors of the IPCC Fourth Assessment Report on Addressing Uncertainties. http://www.ipcc.ch/meetings/ar4-workshops-expressmeetings/uncertainty-guidance-note.pdf. Published July 2005. Accessed May 12, 2014.
33. Atkins D, Best D, Briss PA, et al. Grading quality of evidence and strength of recommendations. BMJ. 2004;328:1490.
34. Schünemann HJ, Schünemann AH, Oxman AD, et al. Grading quality of evidence and strength of recommendations for diagnostic tests and strategies. BMJ. 2008;336:1106-1110.
35. Bruce N, Pruss-Ustun AM, Pope D, Adair-Rohani H, Rehfuess E. 2014 WHO Indoor air quality guidelines: household fuel combustion. Methods used for evidence assessment. Available at http://www.who.int/indoorair/guidelines/hhfc/Evidence-review-methods. pdf. Accessed March 1, 2015.
36. Hass U, Christiansen S, Axelstad M, et al. Evaluation of 22 SIN List 2.0 substances according to the Danish proposal on criteria for endocrine disrupters. Danish Centre on Endocrine Disrupters. http://eng.mst.dk/media/mst/67169/SIN%20report%20and%20Annex. pdf. Published May 2012. Accessed May 12, 2014.
37. Porta M, Zumeta E. Implementing the Stockholm Treaty on persistent organic pollutants. Occup Environ Med. 2002;59:651-652.
38. Valvi D, Mendez MA, Garcia-Esteban R, et al. Prenatal exposure to persistent organic pollutants and rapid weight gain and overweight in infancy. Obesity (Silver Spring). 2014;22:488-496.
39. Gascon M, Vrijheid M, Garí M, et al. Temporal trends in concentrations and total serum burdens of organochlorine compounds from birth until adolescence and the role of breastfeeding. Environ Int. 2015;74:144-151.
40. Clayton MJ. Delphi: a technique to harness expert opinion for critical decision-making tasks in education. Educ Psychol. 1997;17:373-386.
41. Juri P. The Delphi method: Substance, context, a critique and an annotated bibliography. Soc Econ Plann Sci. 1971;5:57-71.
42. Rescher N. Predicting the Future: An Introduction to the Theory of Forecasting. Albany, NY: State University of New York Press; 1997.
43. Arkes HR, Mumpower JL, Stewart TR. Combining expert opinions. Science. 1997;275:461-465.
44. Landeta J. Current validity of the Delphi method in social sciences. Technol Forecast Soc. 2006;73:467-482.
45. McGory ML, Shekelle PG, Ko CY. Development of quality indicators for patients undergoing colorectal cancer surgery. J Natl Cancer Inst. 2006;98:1623-1633.
46. Rao J, Anderson L, Sukumar B, Beauchesne D, Stein T, Frankel R. Engaging communication experts in a Delphi process to identify patient behaviors that could enhance communication in medical encounters. BMC Health Serv Res. 2010;10:97.
47. Cao Y, Calafat AM, Doerge DR, et al. Isoflavones in urine, saliva, and blood of infants: data from a pilot study on the estrogenic activity of soy formula. J Expo Sci Environ Epidemiol. 2009;19:223-234.
48. Davies S, McDonald KM, Schmidt E, Schultz E, Geppert J, Romano PS. Expanding the uses of AHRQ's prevention quality indicators: validity from the clinician perspective. Med Care. 2011;49:679-685.
49. Rice DP, Hodgson TA, Sinsheimer P, Browner W, Kopstein AN. The economic costs of the health effects of smoking, 1984. Milbank Q. 1986;64:489-547.
50. Hodgson TA. Social and economic implications of cancer in the United States. Ann NY Acad Sci. 1981;363:189-204.
51. Weiss KB, Sullivan SD, Lyttle CS. Trends in the cost of illness for asthma in the United States, 1985-1994. J Allergy Clin Immunol. 2000;106:493-499.
52. Hodgson TA, Meiners MR. Cost-of-illness methodology: a guide to current practices and procedures. MilbankMemFundQHealth Soc. 1982;60:429-462.
53. Weinstein MC, Siegel JE, Gold MR, Kamlet MS, Russell LB. Recommendations of the panel on cost-effectiveness in health and medicine. JAMA. 1996;276:1253-1258.
54. Gold MR, Siegel JE, Russell LB, Weinstein MC. Cost-Effectiveness in Health and Medicine. New York, NY: Oxford University Press; 1996.
55. Hsiao WC, Braun P, Dunn DL, et al. An overview of the development and refinement of the Resource-Based Relative Value Scale. The foundation for reform of U. S. physician payment. Med Care. 1992;30:NS1-NS12.
56. Legler J, Fletcher T, Govarts E, et al. Obesity, diabetes and associated costs of exposure to endocrine disrupting chemicals in the European Union. J Clin Endocrinol Metab. 2015;100:1278-1289.
57. Bellanger M, Demeneix B, Grandjean P, Zoeller RT, Bertollini R, Trasande L. Neurobehavioral deficits, diseases and associated costs of exposure to endocrine disrupting chemicals in the European Union. J Clin Endocrinol Metab. 2015;100:1256-1266.
58. Hauser RH, Skakkebaek NE, Hass U, et al. Male reproductive disorders, diseases and costs of exposure to endocrine disrupting chemicals in the European Union. J Clin Endocrinol Metab. 2015;100:1267-1278.
59. Eurostat. Gross domestic product at market prices, million Euro. Available at http://ec.europa.eu/eurostat/tgm/table.do?tab=table&plugin=1&language=en&pcode=tec00001. Accessed March 1, 2015.
60. Gustavsson A, Svensson M, Jacobi F, et al. Cost of disorders of the brain in Europe 2010. Eur Neuropsychopharm. 2011;21:718-779.
61. President's Task Force on Environmental Health Risks and Safety Risks to Children. Eliminating childhood lead poisoning: a federal strategy targeting lead paint hazards. Washington, DC: US Department of Health & Human Services; 2000.
62. Trasande L, Schechter C, Haynes KA, Landrigan PJ. Applying cost analyses to drive policy that protects children: mercury as a case study. Ann NY Acad Sci. 2006;1076:911-923.
63. Trasande L, Liu Y. Reducing the staggering costs of environmental disease in children, estimated at $76.6 billion in 2008. Health Affairs. 2011;30:863-870.
64. Trasande L. Economics of children's environmental health. Mt Sinai J Med. 2011;78:98-106.
65. International Agency for Research on Cancer. Preamble to the IARC Monographs. Scientific Review and Evaluation. http://monographs. iarc.fr/ENG/Preamble/currentbscientificintro0706.php. Published 2006. Accessed May 12, 2014.
66. World Cancer Research Fund/American Institute for Cancer Research. Food, nutrition, physical activity, and the prevention of cancer: a global perspective. Washington, DC: American Institute for Cancer Research; 2007.
67. Bommier A, Villeneuve B. Risk aversion and the value of risk to life. J Risk Insurance. 2012;79:77-104.
68. Cawley J. Contingent valuation analysis of willingness to pay to reduce childhood obesity. Econ Hum Biol. 2008;6:281-292.
69. Hirth RA, Chernew ME, Miller E, Fendrick AM, Weissert WG. Willingness to pay for a quality-adjusted life year: in search of a standard. Med Decis Making. 2000;20:332-342.
70. Ried W. Willingness to pay and cost of illness for changes in health capital depreciation. Health Econ. 1996;5:447-467.
71. Thompson MS. Willingness to pay and accept risks to cure chronic disease. Am J Public Health. 1986;76:392-396.
72. Ackerman F, Heinzerling L. Pricing the priceless: cost-benefit analysis of environmental protection. University of Pennsylvania Law Review. 2002;150:1553-1584.
73. Tsai PL, Hatfield TH. Global benefits of phasing out leaded fuel. J Environ Health. 2011;74:8-15.
74. Trasande L, Massey RI, DiGangi J, Geiser K, Olanipekun AI, Gallagher L. How developing nations can protect children from hazardous chemical exposures while sustaining economic growth. Health Affairs. 2011;30:2400-2409.
75. Atkins D, Eccles M, Flottorp S, et al. Systems for grading the quality of evidence and the strength of recommendations I: critical appraisal of existing approaches. The GRADE Working Group. BMC Health Serv Res. 2004;4:38.